Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo

類似資料

• Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
  著者:: Howell, I, 等
  出版事項: (2024)
• Mepolizumab and exacerbations of refractory eosinophilic asthma.
  著者:: Haldar, P, 等
  出版事項: (2009)
• Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
  著者:: Shrimanker, R, 等
  出版事項: (2017)
• Exacerbations of severe asthma in patients treated with mepolizumab
  著者:: Shrimanker, R, 等
  出版事項: (2018)
• Mepolizumab in refractory eosinophilic asthma.
  著者:: Pavord, I, 等
  出版事項: (2010)